Current Studies

Breast Cancer

Agendia MINT I: Multi-Institutional Neo-adjuvant Therapy MammaPrint Project I

Agendia PROMIS: Prospective Registry of Mammaprint in breast cancer patients with an Intermediate recurrence Score (OncoDx)

ECOG E4112: Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)

Alliance A011202: A Randomized phase III trial comparing axillary lymph node dissection to axillary radiation in Breast Cancer patients (cT1-3 N1) who have positive sentinel lymph node disease after neo-adjuvant chemotherapy

NSABP B-51: A Randomized Phase III clinical trial evaluating post-mastectomy chestwall and regional nodal XRTand post-lumpectomy regional nodal XRT in patients with positive axillary nodes before neoadjuvant chemotherapy who convert to pathologically negative axillary nodes after neoadjuvant chemotherapy (Adjuvant)


GI Cancers

Colon

CTSU CALGB 80702: A Phase III study of Resected Stage III Colon Cancer; FOLFOX x 6 vs 12 + Celecoxib or Placebo (Adjuvant)


Hematology

Pfizer B3281006: A phase 3, Randomized, double-blind study of PF-05280586 versus Rituximab for the first-line treatment of patients with CD20-positive, low tumor burden, follicular lymphoma


Lung Cancer (NSCL)

Alliance A151216: Adjuvant Lung Cancer - Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

Alliance A081105: Randomized double Blind placebo controlled study of Erlotonib or Placebo in patients with completely resected epidermal growth factor receptor (EGFR) mutant Non-Small Cell Lung Cancer

ECOG E4512: A Phase III double blind trial for surgically resected early stage

Non-Small Cell Lung Cancer: Crizotinib versus placebo for patients with Tumors harboring the anaplastic lymphoma kinase (ALK) fusion protein controlled


Prostate

RTOG 0815: A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without short-term Androgen Deprivation Therapy for patients with inter-mediate risk Prostate Cancer

RTOG 0924: A Phase III Randomized Trail: Androgen deprivation therapy and high dose radiotherapy with or without whole pelvic radiotherapy in unfavorable high risk Prostate Cancer


Registry Studies

Celgene CONNECT MM: The Multiple Myeloma Disease Registry

Genentech ML28257: An Observational Cohort study of treatment patterns and outcomes in patients with HER2 positive (HER2+) metastatic breast cancer

SWOG S1204: A Sero-Epidemiologic Survey and Cost-Effectiveness Study of Screening for HIV, Hepatitis B and Hepatitis C Among Newly Diagnosed Cancer Patients


Supportive Care

Amgen 20070782: A randomized, double-blind, placebo-controlled study to evaluate the long-term safety and efficacy of Darbepoetin Alfa administered at 500ug once-every three weeks in anemic subjects with advanced stage Non-Small Cell Lung Cancer (NSCLC) receiving multi-cycle chemotherapy.

For more information and referral, please click here to contact us or call: (760) 416-4736

Note: Trials listed are currently recruiting unless otherwise noted. Recruiting status for trials may change or new trials may be available. Please call for updates.